showed that sEVs-derived miR-1246 is highly expressed in metastatic BC (MDA-MB-231) cells compared to non-metastatic or non-malignant BC cells, and that it promoted BC cells proliferation by targeting cell cycle protein-G2 (CCNG2) (69). This evidence concerns the gene PRRC2A and breast cancer.